Federally-Listed PSOs

Below is a list of PSOs that are currently listed by AHRQ. A health care provider can only obtain the confidentiality and privilege protections of the Patient Safety Act by working with a Federally-listed PSO.

Use the categories on the left to filter the list of PSOs or search a PSO name.

Note: AHRQ updates the PSO information contained within the directories weekly, as needed; changes are made when there are newly listed PSOs and/or when existing information requires revision. Changes that would otherwise be effective on a weekend day or holiday will be effective on the next business day. Information contained in the directories is based on attestations that the PSOs provide. To update PSO contact information, please use the Change of Listing Information form; to update profile information, please go to the PSO PPC Web site.

There are 82 total PSOs listed by AHRQ.

Carolinas Rehabilitation - Patient Safety Organization - P0094
Component of Parent Org(s):
  • Charlotte Mecklenburg Hospital Authority d/b/a Atrium Health
Effective Date and Time of Initial Listing: July 28, 2010 12:01 AM ET
Street Address: 1100 Blythe Blvd, Charlotte, North Carolina 28203
PSO Phone Number: (704) 355-4460
Point of Contact: Danelle Higgins
Point of Contact Phone: 704-355-3704
Point of Contact Email: danelle.higgins@carolinas.org (link is external)
Next biennial attestation for Two Contracts due between 07/28/2020 and 07/27/2022
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: Yes
Strategic Radiology Patient Safety Organization LLC - P0144
Component of Parent Org(s):
  • Strategic Radiology LLC
Effective Date and Time of Initial Listing: June 19, 2013 12:01 AM ET
Street Address: 1001 Riverside Drive, Suite 270, Palmetto, Florida 34221
PSO Phone Number: (810) 210-9885
Point of Contact: Randal Roat
Point of Contact Phone: (810) 210-9885
Point of Contact Email: rroat@strategicradiology.org (link is external)
Next biennial attestation for Two Contracts due between 06/19/2017 and 06/18/2019
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No